Metformin shows greater potential than semaglutide in reducing Alzheimers risk in diabetes type II via dual actions: tackling disease pathways and environmental herpesvirus triggers
Obese patients with the disorder who took semaglutidethe generic name for Ozempic and Wegovyfor around three years experienced fewer flare-ups, and their quality of life also improved, according to a new study presented at the European Academy of Dermatology and Venereology Congress 2024
The efforts we put into this review alone involved more than 40 hours of research, hands-on testing, fact-checking, and comparisons with competitors
Long term supplementation with cyanocobalamin can have systemic toxic effects on the body amd even lead to kidney failure
Ongoing monitoring for effects on thyroid, liver, kidneys, and endocrine systems remains standard of care